Literature DB >> 30529309

Therapeutic medications against diabetes: What we have and what we expect.

Cheng Hu1, Weiping Jia2.   

Abstract

Diabetes has become one of the largest global health and economic burdens, with its increased prevalence and high complication ratio. Stable and satisfactory blood glucose control are vital to reduce diabetes-related complications. Therefore, continuous attempts have been made in antidiabetic drugs, treatment routes, and traditional Chinese medicine to achieve better disease control. New antidiabetic drugs and appropriate combinations of these drugs have increased diabetes control significantly. Besides, novel treatment routes including oral antidiabetic peptide delivery, nanocarrier delivery system, implantable drug delivery system are also pivotal for diabetes control, with its greater efficiency, increased bioavailability, decreased toxicity and reduced dosing frequency. Among these new routes, nanotechnology, artificial pancreas and islet cell implantation have shown great potential in diabetes therapy. Traditional Chinese medicine also offer new options for diabetes treatment. Our paper aim to overview these therapeutic methods for diabetes therapy. Proper combinations of these existing anti-diabetic medications and searching for novel routes are both necessary for better diabetes control.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Diabetes; Drug delivery; Natural product; Treatment

Mesh:

Substances:

Year:  2018        PMID: 30529309     DOI: 10.1016/j.addr.2018.11.008

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  8 in total

1.  Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

Authors:  Xin Zhang; Can Hu; Hai-Ming Wu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

2.  Clinical and Prognostic Relevance of B7-H3 and Indicators of Glucose Metabolism in Colorectal Cancer.

Authors:  Ting Zhang; Yufen Jin; Xin Jiang; Longhai Li; Xiaowei Qi; Yong Mao; Dong Hua
Journal:  Front Oncol       Date:  2020-09-15       Impact factor: 6.244

3.  Sex Differences in Kidney Stone Disease in Chinese Patients with Type 2 Diabetes Mellitus.

Authors:  Ying Xiao; Ling Wei; Xiaofen Xiong; Yuan Yang; Li Li; Ming Yang; Fei Deng; Lin Sun
Journal:  Kidney Dis (Basel)       Date:  2020-02-28

4.  In silico analysis of a potential antidiabetic phytochemical erythrin against therapeutic targets of diabetes.

Authors:  Madhushree M V Rao; T P N Hariprasad
Journal:  In Silico Pharmacol       Date:  2021-01-03

Review 5.  Nanotechnology in the Treatment of Diabetic Complications: A Comprehensive Narrative Review.

Authors:  Yujing He; Abdulrahman Al-Mureish; Na Wu
Journal:  J Diabetes Res       Date:  2021-04-30       Impact factor: 4.011

6.  Trehalose Ameliorates Diabetic Cardiomyopathy: Role of the PK2/PKR Pathway.

Authors:  Yuning Liu; Shi Wu; Qian Zhao; Zhen Yang; Xiaojun Yan; Cairong Li; Wenliang Zha; Wei Yu
Journal:  Oxid Med Cell Longev       Date:  2021-12-21       Impact factor: 6.543

7.  The possible protective and therapeutic effects of ginger and cinnamon on the testis and coda epididymis of streptozotocin-induced-diabetic rats: Histological and biochemical studies.

Authors:  Khadija Abdul Jalil Faddladdeen
Journal:  Saudi J Biol Sci       Date:  2022-09-17       Impact factor: 4.052

Review 8.  Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy.

Authors:  Saikat Dewanjee; Pratik Chakraborty; Biswajit Mukherjee; Vincenzo De Feo
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.